In normal and premalignant cells, TGF-β strengthens homeostasis and inhibits tumor progression by inducing cell arrest, differentiation, and apoptosis, directly or indirectly through its impact on the matrix (including inhibition of inflammation and matrix-derived mitogen). The gene discussed is TGFB1; the disease is neoplasm.